EXPESICOR
Expesicor was focused on discovering treatments for Epilepsy and neurodegenerative disorders.
EXPESICOR
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Missoula, Montana, United States
Country:
United States
Website Url:
http://www.expesicor.com
Total Employee:
1+
Status:
Closed
Total Funding:
2.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Namecheap DNS DreamHost Hosting ProtonMail
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Renew Biopharma Inc.
Pre-clinical stage syn-bio creating proprietary drug molecules to treat neuroinflammatory diseases .
Current Employees Featured
Founder
Official Site Inspections
http://www.expesicor.com
- Host name: billscanvasshop.org
- IP address: 173.236.178.188
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Expesicor"
Expesicor - Crunchbase Company Profile & Funding
Organization. Expesicor . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Bleeding-edge drug discovery for neurological …See details»
Expesicor 2025 Company Profile: Valuation, Funding & Investors
Expesicor is headquartered in Missoula, MT. What is the size of Expesicor? Expesicor has 3 total employees. What industry is Expesicor in? Expesicor’s primary industry is Drug Discovery. Is …See details»
Expesicor - VentureRadar
Branched siRNA is a novel oligonucleotide architecture that has shown potent ability to silence gene expression in the central nervous system (CNS) and can be applied across multiple …See details»
Expesicor Inc. Company Profile | Missoula, MT - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Expesicor Inc. of Missoula, MT. Get the latest business insights from Dun & Bradstreet.See details»
Expesicor | Kalispell, MT, US Startup - Gust
Mar 1, 2016 Expesicor is a Montana-based privately held company that focuses on preventing, treating, and curing neurological disorders. Our approaches are different. We explore new and …See details»
Expesicor - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 19, 2025 Expesicor is a funded company based in Kalispell (United States), founded in 2008. It operates as a Drug screening assay development aimed at identifying neuroprotective …See details»
Expesicor - Overview, News & Similar companies | ZoomInfo.com
Jul 16, 2020 Expesicor is a privately held, Montana-based company focused on preventing, treating, and curing neurological disorders. Expesicor's development pi peline includes …See details»
Expesicor Overview | SignalHire Company Profile
Expesicor is a Montana-based privately held company that focuses on preventing, treating, and curing neurological disorders.Our approaches are different. ... Organization Website: …See details»
Expesicor, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Expesicor, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Disease Domain:Nervous System Diseases, Endocrinology and ...See details»
Expesicor LLC - Company Profile and News - Bloomberg Markets
Company profile page for Expesicor LLC including stock price, company news, executives, board members, and contact informationSee details»
Expesicor Company Insights, Tech Stack, and Competitors | 6sense
Expesicor is a Montana-based privately held company that focuses on preventing, treating, and curing neurological disorders. Our approaches are different. We explore new and different …See details»
Expesicor - Contacts, Employees, Board Members, Advisors & Alumni
Bleeding-edge drug discovery for neurological disorders.See details»
Expesicor - Golden
Expesicor is a drug discovery company for neurological disorders founded in 2002 by David Booth. Overview Structured Data Issues Contributors Activity. Contents. expesicor.com. Is a. …See details»
Expesicor - 2025 Funding Rounds & List of Investors - Tracxn
Apr 25, 2025 Dotz - Melbourne based, raised a funding of $2.47M in Post IPO round held on Apr 11, 2025.; LiveKit - Saratoga based, raised a funding of $45M in Series B round held on Apr …See details»
Expesicor LLC Company Profile | Kalispell, MT - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Expesicor LLC of Kalispell, MT. Get the latest business insights from Dun & Bradstreet.See details»
Biotech: Expesicor Inc. launches Missoula lab, jobs in search of ...
Dec 13, 2019 Expesicor also has received $400,000 from the National Institutes of Health to further develop an imaging agent to identify pain in a patient. As it currently stands, Booth …See details»
Expesicor LLC | Alzheimer's Drug Discovery Foundation
Sep 11, 2017 Biotechnology/For Profit Organization Type; $0 Funding Amount ... Status; Expesicor LLC. Braxton Norwood, PhD | Repurposing EXP-1601 for Alzheimer's Disease: …See details»
Expesicor | CipherBio
Explore Expesicor's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
EXP-200 - Drug Targets, Indications, Patents - Synapse
EXP-200, Initially developed by Expesicor, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases,Endocrinology and ...See details»
TJNAF25 Expressions of Interest | U.S. DOE Office of Science(SC)
Apr 15, 2025 The following information was posted to SAM.gov on April 15, 2025: All interested parties are requested to submit an Expression of Interest (EOI) to …See details»